- In August 2026, FIGS reported quarterly earnings that exceeded expectations, with earnings per share reaching $0.15 and margins improving, which fueled renewed investor attention on its direct-to-consumer healthcare apparel model.
- This stronger-than-expected profitability has prompted a fresh look at FIGS’ business fundamentals, particularly how margin resilience may influence its long-term growth profile and valuation.
- We’ll now examine how FIGS’ better-than-expected quarterly earnings and margin improvement could reshape its existing investment narrative and future assumptions.
The future of work is here. Discover the 38 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
FIGS Investment Narrative Recap
To own FIGS, you need to believe its direct to consumer model can keep monetizing a loyal healthcare customer base while maintaining healthy margins in a competitive, tariff exposed category. The recent Q2 earnings beat and margin improvement support that thesis in the near term, but also sharpen the main catalyst and risk: whether FIGS can grow profitably without heavy promotions while managing tariff and sourcing pressures that could still weigh on profitability.
The Q2 2026 report is the clearest recent marker for that trade off. FIGS lifted sales to US$196.62M and delivered diluted EPS of US$0.15, well ahead of the prior year, while also expanding net income. At the same time, management increased its share repurchase authorization by US$100M to a total of US$200M, tying capital returns directly to a period of stronger earnings and reminding investors that execution quality, not just revenue growth, sits at the center of the current FIGS story.
Yet despite the stronger quarter, investors should be aware that FIGS still faces meaningful tariff and sourcing risk that could...
Read the full narrative on FIGS (it's free!)
FIGS' narrative projects $918.9 million revenue and $72.9 million earnings by 2029.
Uncover how FIGS' forecasts yield a $18.62 fair value, a 21% upside to its current price.
Exploring Other Perspectives
Some of the most pessimistic analysts were assuming FIGS would reach only about US$887.4M in revenue and US$72.2M in earnings by 2029, so this earnings surprise may eventually push those cautious views closer to the more optimistic catalyst that FIGS can grow profitably while expanding its customer base, but for now it is a reminder that your own view should sit somewhere along a wide spectrum of reasonable opinions.
Explore 5 other fair value estimates on FIGS - why the stock might be worth 39% less than the current price!
The Verdict Is Yours
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your FIGS research is our analysis highlighting 3 key rewards that could impact your investment decision.
- Our free FIGS research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate FIGS' overall financial health at a glance.
Curious About Other Options?
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
- Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 30 best rare earth metal stocks of the very few that mine this essential strategic resource.
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com